Resveratrol in Knee Osteoarthritis (NCT02905799) | Clinical Trial Compass
CompletedPhase 3
Resveratrol in Knee Osteoarthritis
France142 participantsStarted 2017-11-09
Plain-language summary
The purpose of this study is to determine whether resveratrol is effective in the treatment of painful knee osteoarthritis.
Who can participate
Age range40 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 40 years-old
* Knee osteoarthritis fulfilling 1986 American College of Rheumatology (ACR) criteria
* Pain on numeric rating scale ≥ 40/100
* Symptom duration ≥ 1 month
* Kellgren and Lawrence X-Ray score 1, 2 or 3
* Written consent obtained
* Health insurance cover
Exclusion Criteria:
* History of symptomatic crystal or inflammatory arthritis
* Knee surgery ≤ 1 year
* Knee trauma ≤ 2 months
* Knee intra-articular injections of corticosteroids and/or hyaluronic acid ≤ 2 months
* Neurologic disorders involving the lower limbs
* Patient not understanding and not speaking french
* Participation in another biomedical research
* Contraindication to resveratrol or hypersensitivity to any of its constituents
* Current use of intramuscular, intravenous or oral corticosteroids
* Uncontrolled diseases that may require intramuscular, intravenous or oral corticosteroids
* Current use of anticoagulants
What they're measuring
1
Mean change from baseline in knee pain in the previous 48 hours